Filing Details
- Accession Number:
- 0001209191-21-010200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-12 17:01:29
- Reporting Period:
- 2021-02-11
- Accepted Time:
- 2021-02-12 17:01:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1512985 | A. Michael Desjardin | C/O Horizon Therapeutics Plc, Connaught House 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-02-11 | 10,786 | $90.00 | 101,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.
Billionaire Hedge Funds
